Health & Fitness
Health and Fitness
Health and Fitness
Mon, February 9, 2009 Synovis Life Technologies to Present at 21st Annual Roth Capital Partners Growth Stock Conference Feb. 18
ST. PAUL, Minn.--([ BUSINESS WIRE ])--Synovis Life Technologies, Inc. (NASDAQ: SYNO), a diversified medical device company, will present at the 21st Annual Roth Capital Partners Growth Stock Conference on Wednesday, Feb. 18, 2009, at 9 a.m. PT. Richard W. Kramp, president and chief executive officer, and Brett A. Reynolds, chief financial officer, will discuss the company's recent performance and market opportunities.
The presentation slides will be posted on the company's Web site on Feb. 18 and will be available for approximately one week.
The Roth Capital Partners conference will be held at The Ritz-Carlton, Dana Point, Calif., Feb. 16 to 18.
As previously announced, Synovis will release its fiscal first quarter results on Feb. 25, one week after the Roth conference.
About Synovis Life Technologies
Synovis Life Technologies, Inc., based in St. Paul, Minn., is a diversified medical device company that develops, manufactures and markets medical devices for the surgical treatment of disease. The company's products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools – all designed to reduce risks and/or facilitate critical surgeries, improve patient outcomes and reduce healthcare costs. For additional information on Synovis Life Technologies and its products, visit the company's Web site at [ www.synovislife.com ].
